Clinical Trials Browser

Phase 3 × INDUSTRY × Hematologic Neoplasms × Clear all

Hematologic Neoplasms

NCT02730299 2026-02-25

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06652633 2026-02-05

Hesperia

Phase 3 Recruiting

546 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT04260698 2025-07-02

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

Phase 3 Completed

36 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT06401356 2025-06-22

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Phase 3 Recruiting

50 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT01437787 2025-03-05

JAKARTA

Phase 3 Completed

289 enrolled 1 FDA

Other hematologic neoplasm

Hematologic Neoplasms

NCT05438498 2023-09-08

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Phase 3 Terminated

550 enrolled

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Phase 3 Completed

1,718 enrolled 22 charts

Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT02999854 2022-05-24

HATCY

Phase 3 Terminated

63 enrolled 14 charts

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00519090 2011-11-07

ENEST

Phase 3 Terminated

6 enrolled 6 charts

MyeloidOther hematologic neoplasm

Bone Marrow Diseases, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT00044759 2007-10-10

Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma

Phase 3 Completed

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

Clinical Trials

MK-3475-587

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Hesperia

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

JAKARTA

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

HATCY

ENEST

Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma